Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-012596

President sold 30,000 shares at an average $61.49 ($1,844,636)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-02-17 Option exercise +15,000 $6.55 $98,250 15,000 D: show line 1 in the form
RUBINSTEIN JULIE President 2021-02-17 Sale −5,201 $61.63 $320,538 9,799 D: show line 2 in the form
RUBINSTEIN JULIE President 2021-02-17 Sale −9,799 $62.28 $610,282 0 D: show line 3 in the form
RUBINSTEIN JULIE President 2021-02-18 Option exercise +15,000 $6.55 $98,250 15,000 D: show line 4 in the form
RUBINSTEIN JULIE President 2021-02-18 Sale −5,892 $60.49 $356,407 9,108 D: show line 5 in the form
RUBINSTEIN JULIE President 2021-02-18 Sale −9,108 $61.20 $557,410 0 D: show line 6 in the form
Open-market sales · 30,000 sh · avg $61.49 · $1,844,636

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
RUBINSTEIN JULIE President 2021-02-17 Option exercise · Stock Option (Right to Buy) −15,000 315,000 D: show line 7 in the form
RUBINSTEIN JULIE President 2021-02-18 Option exercise · Stock Option (Right to Buy) −15,000 300,000 D: show line 8 in the form
Loading xslF345X03/doc4.xml…